New tentative approval for Sandoz Inc drug rifaximin
Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There […]
New tentative approval for Sandoz Inc drug rifaximin Read Post »
Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There […]
New tentative approval for Sandoz Inc drug rifaximin Read Post »
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There
New tentative approval for Sandoz Inc drug rifaximin Read Post »
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Icosapent ethyl is the generic ingredient in two branded drugs marketed by Apotex, Dr Reddys, Hikma, Strides Pharma, Teva Pharms
New tentative approval for Ascent Pharms drug icosapent ethyl Read Post »
Dasatinib is the generic ingredient in two branded drugs marketed by Apotex and Bristol Myers Squibb and is included in
New tentative approval for Teva Pharms drug dasatinib Read Post »
Dasatinib is the generic ingredient in two branded drugs marketed by Apotex and Bristol Myers Squibb and is included in
New tentative approval for Teva Pharms drug dasatinib Read Post »
Icosapent ethyl is the generic ingredient in two branded drugs marketed by Apotex, Dr Reddys, Hikma, Strides Pharma, Teva Pharms
New tentative approval for Ascent Pharms drug icosapent ethyl Read Post »
Dasatinib is the generic ingredient in two branded drugs marketed by Apotex and Bristol Myers Squibb and is included in
New tentative approval for Teva Pharms drug dasatinib Read Post »